RxDoctor Payments Data

Evan Peskin, MD

Interventional Pain Medicine · Flint, MINPI 1669904959

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,875 of the $71,920 with a category attached, or 73.5%. Nalu Medical, Inc. accounts for 79.5% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $51,749, more than ten times the $1,233 reported in 2021. Among interventional pain medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,920in general payments, 2019–2025

Across 278 payments — averaging $258.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nalu Medical, Inc.$57K
  • Saluda Medical Americas, Inc.$2K
  • Medtronic$2K
  • Boston Scientific$2K
  • Abbott$2K
  • Genesys Orthopedics Systems, L.L.C.$1K
  • plus $5K from 16 others

What the payments were for

  • Consulting fees$52,87574%
  • Grants$1620%
  • Travel & lodging$8,15611%
  • Food & beverage$10,71215%
  • Gifts$150%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,920 in reported general payments places this provider in the 95th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$51,773
Medicare patients
158
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl55$3,507
Buprenorphine11$2,886
Pregabalin94$1,729
Diclofenac Sodium110$1,628
Tizanidine Hcl108$1,078
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen86$742
Lidocaine22$686
Duloxetine Hcl48$486
Acetaminophen-CodeineAcetaminophen With Codeine24$386
Gabapentin35$351
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$270
Methylprednisolone25$166
Celecoxib12$133
Cyclobenzaprine Hcl16$78
Tramadol Hcl15$66

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →